Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 25.43T | 11.74T | 11.71T | 13.61T | 13.12T | 11.19T |
Gross Profit | 13.80T | 11.74T | 11.71T | 13.57T | 15.99T | 11.19T |
EBITDA | 3.63T | 4.41T | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | 1.55T | 1.02T | 739.00B | 2.48T | 3.30T | 2.35T |
Balance Sheet | ||||||
Total Assets | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
Cash, Cash Equivalents and Short-Term Investments | 49.38T | 7.28T | 8.41T | 15.90T | 35.62T | 64.51T |
Total Debt | 68.73T | 43.13T | 65.54T | 72.12T | 74.09T | 59.49T |
Total Liabilities | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
Stockholders Equity | 17.76T | 17.45T | 16.78T | 16.47T | 23.01T | 20.66T |
Cash Flow | ||||||
Free Cash Flow | -2.48T | -14.70T | 511.93B | -1.37T | 3.65T | 7.99T |
Operating Cash Flow | -2.14T | -14.04T | 1.81T | -222.12B | 5.90T | 10.02T |
Investing Cash Flow | -1.79T | -3.14T | 1.84T | -13.01T | -6.60T | -7.59T |
Financing Cash Flow | 721.97B | 13.46T | 11.82T | 9.26T | -1.35T | 404.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $3.91B | 19.97 | 12.12% | 0.90% | 19.47% | 48.35% | |
74 Outperform | $3.83B | 14.30 | 7.81% | 3.07% | 3.00% | 42.78% | |
70 Outperform | $5.84B | 4.83 | 22.42% | 2.13% | -42.92% | -21.46% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | $3.59B | 8.51 | 10.91% | 2.13% | -57.78% | -67.92% | |
64 Neutral | $2.17B | 6.54 | 13.26% | 0.59% | -47.41% | -18.95% | |
63 Neutral | $4.31B | 11.01 | 9.57% | 3.35% | -6.63% | 241.66% |